미국 - 영어 - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - foscarnet sodium (unii: 964ys0oog1) (foscarnet - unii:364p9rvw4x) - foscarnet sodium injection is indicated for the treatment of cmv retinitis in patients with acquired immunodeficiency syndrome (aids). combination therapy with foscarnet sodium and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug. safety and efficacy of foscarnet sodium have not been established for treatment of other cmv infections (e.g., pneumonitis, gastroenteritis); congenital or neonatal cmv disease; or nonimmunocompromised individuals. foscarnet sodium injection is indicated for the treatment of acyclovir-resistant mucocutaneous hsv infections in immunocompromised patients. safety and efficacy of foscarnet sodium have not been established for treatment of other hsv infections (e.g., retinitis, encephalitis); congenital or neonatal hsv disease; or hsv in nonimmunocompromised individuals. foscarnet sodium injection is contraindicated in patients with clinically significant hypersensitivity to foscarnet sodium.

미국 - 영어 - NLM (National Library of Medicine)

amneal pharmaceuticals llc - foscarnet sodium (unii: 964ys0oog1) (foscarnet - unii:364p9rvw4x) - cmv retinitis foscarnet sodium injection is indicated for the treatment of cmv retinitis in patients with acquired immunodeficiency syndrome (aids). combination therapy with foscarnet sodium injection and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug. safety and efficacy of foscarnet sodium injection have not been established for treatment of other cmv infections (e.g., pneumonitis, gastroenteritis); congenital or neonatal cmv disease; or nonimmunocompromised individuals. mucocutaneous acyclovir resistant hsv infections foscarnet sodium injection is indicated for the treatment of acyclovir-resistant mucocutaneous hsv infections in immunocompromised patients. safety and efficacy of foscarnet sodium injection have not been established for treatment of other hsv infections (e.g., retinitis, encephalitis); congenital or neonatal hsv disease; or hsv in nonimmunocompromised individuals. foscarnet sodium injection is contraindicated in patients with clinically significant hypersensitivity to foscarnet sodium.

미국 - 영어 - NLM (National Library of Medicine)

astrazeneca lp - foscarnet sodium (unii: 964ys0oog1) (foscarnet - unii:364p9rvw4x) - injection - 24 mg in 1 ml - foscavir is indicated for the treatment of cmv retinitis in patients with acquired immunodeficiency syndrome (aids). combination therapy with foscavir and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug. safety and efficacy of foscavir have not been established for treatment of other cmv infections (e.g., pneumonitis, gastroenteritis); congenital or neonatal cmv disease; or nonimmunocompromised individuals. foscavir is indicated for the treatment of acyclovir-resistant mucocutaneous hsv infections in immunocompromised patients. safety and efficacy of foscavir have not been established for treatment of other hsv infections (e.g., retinitis, encephalitis); congenital or neonatal hsv disease; or hsv in nonimmunocompromised individuals. foscavir is contraindicated in patients with clinically significant hypersensitivity to foscarnet sodium.

사우디아라비아 - 영어 - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

boston oncology arabia, saudi arabia - foscarnet - solution for infusion - 24 mg/ml

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - foscarnet sodium - solution for infusion - 24mg/1ml

미국 - 영어 - NLM (National Library of Medicine)

clinigen limited - foscarnet sodium (unii: 964ys0oog1) (foscarnet - unii:364p9rvw4x) - foscavir is indicated for the treatment of cmv retinitis in patients with acquired immunodeficiency syndrome (aids). combination therapy with foscavir and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug. safety and efficacy of foscavir have not been established for treatment of other cmv infections (e.g., pneumonitis, gastroenteritis); congenital or neonatal cmv disease; or nonimmunocompromised individuals. foscavir is indicated for the treatment of acyclovir-resistant mucocutaneous hsv infections in immunocompromised patients. safety and efficacy of foscavir have not been established for treatment of other hsv infections (e.g., retinitis, encephalitis); congenital or neonatal hsv disease; or hsv in nonimmunocompromised individuals. foscavir is contraindicated in patients with clinically significant hypersensitivity to foscarnet sodium.

이스라엘 - 영어 - Ministry of Health

megapharm ltd - foscarnet trisodium hexahydrate - solution for infusion - foscarnet trisodium hexahydrate 24 mg/ml - foscarnet - treatment of cmv retinitis in patients with aquired immunodeficiency syndrome (aids).

이스라엘 - 영어 - Ministry of Health

megapharm ltd - foscarnet trisodium hexahydrate - solution for infusion - foscarnet trisodium hexahydrate 24 mg/ml - foscarnet - treatment of cmv retinitis in patients with aquired immunodeficiency syndrome (aids).

미국 - 영어 - NLM (National Library of Medicine)

clinigen limited - foscarnet sodium (unii: 964ys0oog1) (foscarnet - unii:364p9rvw4x) - foscavir is indicated for the treatment of cmv retinitis in patients with acquired immunodeficiency syndrome (aids). combination therapy with foscavir and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug. safety and efficacy of foscavir have not been established for treatment of other cmv infections (e.g., pneumonitis, gastroenteritis); congenital or neonatal cmv disease; or nonimmunocompromised individuals. foscavir is indicated for the treatment of acyclovir-resistant mucocutaneous hsv infections in immunocompromised patients. safety and efficacy of foscavir have not been established for treatment of other hsv infections (e.g., retinitis, encephalitis); congenital or neonatal hsv disease; or hsv in nonimmunocompromised individuals. foscavir is contraindicated in patients with clinically significant hypersensitivity to foscarnet sodium.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - foscarnet sodium hexahydrate 24 mg/ml - solution for infusion - 24 mg/ml - active: foscarnet sodium hexahydrate 24 mg/ml - treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids). treatment of acyclovir resistant herpes simplex virus (hsv) infections in immunocompromised patients. the safety and efficacy of foscavir for the treatment of other hsv infections (e.g. retinitis, encephalitis); congenital or neonatal disease; or hsv in immunocompetent individuals has not been established.